Additional file 1: of Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1Îą/VEGFA signalling in hepatocellular carcinoma

Table S1. Sequences of primers and probe sequences used in this study. (DOC 14 kb

Additional file 2: of Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1Îą/VEGFA signalling in hepatocellular carcinoma

Figure S1. (A) The infection efficiencies of lncRNA UBE2CP3 in HepG2 and SMMC-7721 were screened by qRT-PCR. (B) The schematic diagram for the co-culture system. (C) 12 kinds of common angiogenic factors were detected by qRT-PCR.. (TIF 24 kb

Additional file 7: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Figure S2. Functions of the differentially expressed genes in glucose and glycogen metabolism. These genes included HK2, PDP2, G6PD, PGK1, PHKA1, PYGL, PDK1, and PKM2. (TIF 1108 kb

Additional file 8: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Figure S3. The pairwise comparison matrix used in the AHP model. The weighting coefficients of the criteria layer were calculated on the basis of the maximum eigenvalue using the sum-product method. (TIF 481 kb

Additional file 3: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Determination of the positive standard for CTCs counting. (DOCX 133 kb

Additional file 6: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Table S4. Gene information on the Human Glucose Metabolism Array. (DOCX 19 kb

Additional file 2: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Table S2. Antibodies used in Western blot analysis. (DOCX 21 kb

Additional file 5: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Figure S1. Migration and invasion assays of the five PCa cell lines. (A–B) Representative images and statistical comparison between PC-3 M 2B4 and PC-3 M 1E8 cells in wound healing (A, 100×) and Transwell (B, 200×) assays. (C–D) Representative images and statistical comparison among LNCAP, PC-3, and DU145 cells by wound healing (C, 100×) and Transwell (D, 200×) assays. ***P < 0.001; Scale bar = 150 μm. (TIF 19013 kb

Additional file 11: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Table S7. Metabolic and EMT subtypes of CTCs in non-metastatic and metastatic PCa patients (Cohort 2). (DOCX 24 kb

Additional file 1: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Table S1. Primer sequences for qRT-PCR. (DOCX 20 kb